Intuitive Surgical, Inc. $ISRG Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 857,315 shares of the medical equipment provider’s stock after buying an additional 39,433 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.24% of Intuitive Surgical worth $383,417,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC raised its stake in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. Sivia Capital Partners LLC lifted its holdings in Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after buying an additional 34 shares during the last quarter. Schnieders Capital Management LLC. grew its position in shares of Intuitive Surgical by 38.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after acquiring an additional 268 shares in the last quarter. Rossby Financial LCC increased its holdings in shares of Intuitive Surgical by 55.1% in the 2nd quarter. Rossby Financial LCC now owns 304 shares of the medical equipment provider’s stock valued at $165,000 after acquiring an additional 108 shares during the last quarter. Finally, Advisory Alpha LLC raised its position in shares of Intuitive Surgical by 7.0% during the 2nd quarter. Advisory Alpha LLC now owns 2,253 shares of the medical equipment provider’s stock valued at $1,224,000 after acquiring an additional 147 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, Director Gary S. Guthart sold 24,500 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total value of $12,987,450.00. Following the transaction, the director owned 3,694 shares of the company’s stock, valued at $1,958,189.40. The trade was a 86.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Myriam Curet sold 421 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the sale, the executive vice president directly owned 409 shares of the company’s stock, valued at approximately $202,438.64. This represents a 50.72% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 56,189 shares of company stock valued at $30,785,441 in the last three months. 0.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

ISRG has been the subject of a number of research reports. HSBC lifted their price objective on shares of Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a report on Monday, January 26th. Piper Sandler reaffirmed an “overweight” rating and set a $620.00 price objective (up from $610.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Royal Bank Of Canada increased their price objective on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Raymond James Financial raised their target price on shares of Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Finally, UBS Group set a $570.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a research report on Tuesday. Two research analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $615.86.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $506.17 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $603.88. The firm has a market capitalization of $179.76 billion, a PE ratio of 64.15, a P/E/G ratio of 3.83 and a beta of 1.65. The company’s 50 day simple moving average is $532.31 and its 200 day simple moving average is $511.29.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. During the same period last year, the company posted $2.21 EPS. The firm’s quarterly revenue was up 18.8% on a year-over-year basis. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.